Schwartz B S, Edgington T S
J Exp Med. 1981 Sep 1;154(3):892-906. doi: 10.1084/jem.154.3.892.
It has previously been described that soluble antigen:antibody complexes in antigen excess can induce an increase in the procoagulant activity of human peripheral blood mononuclear cells. It has been proposed that this response may explain the presence of fibrin in immune complex-mediated tissue lesions. In the present study we define cellular participants and their roles in the procoagulant response to soluble immune complexes. Monocytes were shown by cell fractionation and by a direct cytologic assay to be the cell of origin of the procoagulant activity; and virtually all monocytes were able to participate in the response. Monocytes, however, required the presence of lymphocytes to respond. The procoagulant response required cell cooperation, and this collaborative interaction between lymphocytes and monocytes appeared to be unidirectional. Lymphocytes once triggered by immune complexes induced monocytes to synthesize the procoagulant product. Intact viable lymphocytes were required to present instructions to monocytes; no soluble mediator could be found to subserve this function. Indeed, all that appeared necessary to induce monocytes to produce procoagulant activity was an encounter with lymphocytes that had previously been in contact with soluble immune complexes. The optimum cellular ratio for this interaction was four lymphocytes per monocyte, about half the ratio in peripheral blood. The procoagulant response was rapid, reaching a maximum within 6 h after exposure to antigen:antibody complexes. The procoagulant activity was consistent with tissue factor because Factors VII and X and prothrombin were required for clotting of fibrinogen. WE propose that this pathway differs from a number of others involving cells of the immune system. Elucidation of the pathway may clarify the role of this lymphocyte-instructed monocyte response in the Shwartzman phenomenon and other thrombohemorrhagic events associated with immune cell function and the formation of immune complexes.
此前已有描述,抗原过量时的可溶性抗原:抗体复合物可诱导人外周血单个核细胞的促凝活性增加。有人提出,这种反应可能解释了免疫复合物介导的组织损伤中纤维蛋白的存在。在本研究中,我们确定了细胞参与者及其在对可溶性免疫复合物的促凝反应中的作用。通过细胞分级分离和直接细胞学检测表明,单核细胞是促凝活性的细胞来源;实际上所有单核细胞都能够参与该反应。然而,单核细胞需要淋巴细胞的存在才能做出反应。促凝反应需要细胞间的协作,淋巴细胞与单核细胞之间的这种协同相互作用似乎是单向的。免疫复合物一旦触发淋巴细胞,就会诱导单核细胞合成促凝产物。完整存活的淋巴细胞需要向单核细胞传达指令;未发现有可溶性介质能发挥此功能。事实上,诱导单核细胞产生促凝活性似乎只需要与先前接触过可溶性免疫复合物的淋巴细胞相遇即可。这种相互作用的最佳细胞比例是每单核细胞有四个淋巴细胞,约为外周血中比例的一半。促凝反应迅速,在接触抗原:抗体复合物后6小时内达到最大值。促凝活性与组织因子一致,因为纤维蛋白原的凝血需要因子VII、X和凝血酶原。我们提出,该途径不同于其他一些涉及免疫系统细胞的途径。阐明该途径可能会澄清这种淋巴细胞指导的单核细胞反应在施瓦茨曼现象以及其他与免疫细胞功能和免疫复合物形成相关的血栓出血事件中的作用。